After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ORKA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Oruka Therapeutics Inc is $582.73M. A total of 0.54 million shares were traded on the day, compared to an average of 269.42K shares.
In the most recent transaction, Venrock Healthcare Capital Par bought 88,794 shares of ORKA for 11.44 per share on Feb 14 ’25. After the transaction, the 10% Owner now owns 4,148,428 company shares. In a previous transaction on Feb 13 ’25, Venrock Healthcare Capital Par bought 14,950 shares at 11.63 per share. ORKA shares that 10% Owner owns now total 4,059,634.
Among the insiders who bought shares, Venrock Healthcare Capital Par acquired of 8,971 shares on Feb 12 ’25 at a per-share price of $11.86. This resulted in the 10% Owner holding 4,044,684 shares of ORKA after the transaction. In another insider transaction, Venrock Healthcare Capital Par bought 9,593 shares at $10.95 per share on Feb 11 ’25. Company shares held by the 10% Owner now total 4,035,713.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ORKA has a high of $31.13 and a low of $5.49.
As of this writing, ORKA has an earnings estimate of -$0.53 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.4 per share and a lower estimate of -$0.6. The company reported an EPS of -$1.46 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ORKA is Buy with a score of 4.80.
